SCHEMBL5064900

SCHEMBL5064900

Nc1nc(N)c(S(N)(=O)=O)c(-c2ccccc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 10/20 0.50
ADORA2A P29274 10/20 0.50
CSNK1A1 P48729 1/20 0.49
CLK4 Q9HAZ1 1/20 0.49
CA12 O43570 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
CA7 P43166 1/20 0.47
DHFR P00374 1/20 0.47
PIK3CG P48736 1/20 0.47
NUDT1 P36639 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 1/20 0.46
JAK2 O60674 1/20 0.46
GMNN O75496 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16463518 0.75 CSNK1A1 (0.61) ADORA1ADORA2ACSNK1A1CLK4DHFR
SCHEMBL11882940 0.74 CA1 (0.38) CA12CA1CA2CA9CA7
SCHEMBL5064901 0.72 DHFR (0.50) ADORA1ADORA2ACSNK1A1CLK4CA12
SCHEMBL2473930 0.72 DHFR (0.58) ADORA1ADORA2ACSNK1A1CLK4DHFR
SCHEMBL27612323 0.71 CSNK1A1 (0.55) ADORA1ADORA2ACSNK1A1CLK4DHFR
Hydrochloric Acid SCHEMBL15487768 0.71 DHFR (0.56) ADORA1ADORA2ACSNK1A1CLK4DHFR
SCHEMBL28447630 0.70 CSNK1A1 (0.50) ADORA1ADORA2ACSNK1A1CLK4DHFR
Ampyrimine SCHEMBL1230765 0.69 DHFR (0.61) ADORA1ADORA2ACSNK1A1CLK4DHFR
SCHEMBL27716588 0.69 CSNK1A1 (0.53) ADORA1ADORA2ACSNK1A1CLK4DHFR
SCHEMBL544518 0.69 CA1 (0.49) CA12CA1CA2CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008079907-A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY RIGEL PHARMACEUTICALS, INC. (US) 2008-07-03 WO claimed